Valeant Pharmaceuticals reported CAD622M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.23B 197M
Ani Pharmaceuticals ANIP:US $ 28.82M 1.89M
Aurora Cannabis Inc ACB:CN 43.17M 3.69M
Biogen BIIB:US $ 634.9M 153M
Bristol Myers Squibb BMY:US $ 1.83B 523M
Canopy Growth Corp WEED:CN C$ 129.26M 21.83M
Catalent CTLT:US $ 207M 21M
Corcept Therapeutics CORT:US $ 37.55M 5.26M
Danaher DHR:US $ 2.09B 202M
Eli Lilly And LLY:US $ 1.56B 34.1M
Endo International Ordinary Shares ENDP:US 226M 18.48M
Gilead Sciences GILD:US $ 1.08B 567M
Horizon Pharma HZNP:US 372.73M 26.22M
JAZZ PHA JAZZ:US 308.81M 53.95M
Lannett LCI:US $ 17.57M 1.22M
Nektar Therapeutics NKTR:US $ 27.34M 4.8M
Pacira Pharmaceuticals PCRX:US $ 64.26M 13.06M
Perrigo Ordinary Shares PRGO:US 282.3M 13M
Phibro Animal Health PAHC:US $ 52.43M 4.05M
Prestige Brands PBH:US $ 64.74M 1.48M
Revance Therapeutics RVNC:US $ 43.97M 588K
Supernus Pharmaceuticals SUPN:US $ 90.46M 11.02M
Valeant Pharmaceuticals VRX:CN C$ 622M 58M
Vertex Pharmaceuticals VRTX:US $ 215.2M 39.96M
Zoetis ZTS:US $ 465M 128M